Investors Might Be Losing Patience for Ocular Therapeutix's (NASDAQ:OCUL) Increasing Losses, as Stock Sheds 12% Over the Past Week

Yahoo FinanceDec 19 09:31 ET

Possible Bearish Signals With Ocular Therapeutix Insiders Disposing Stock

Simply Wall StDec 14 08:47 ET

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 13 07:00 ET

Express News | Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 13 07:00 ET

Ocular Therapeutix, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference in January 2025

Quiver QuantitativeDec 10 07:42 ET

Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $21

Moomoo NewsDec 5 12:35 ET · Ratings